首页 | 本学科首页   官方微博 | 高级检索  
检索        

继发性磺脲类药物失效的2型糖尿病三种治疗方式的观察与评价
引用本文:赖晓阳,邹文华,等.继发性磺脲类药物失效的2型糖尿病三种治疗方式的观察与评价[J].江西医学院学报,1999,39(3):75-78.
作者姓名:赖晓阳  邹文华
作者单位:Department of Endocrinology,Second Affiliated Hospital,Jiangxi Medical College Nanchang 330006
摘    要:对60 例继发性磺脲类药物失效的2 型糖尿病分别采用了二甲双胍与拜糖平联合治疗(A组);小剂量诺和灵30R胰岛素与拜糖平合用(B组),小剂量诺和灵30R胰岛素与二甲双胍合用(C组),三组病人均在饮食量和活动量相对衡定的条件下,连续治疗三个月并行对照观察,结果表明:三组病人空腹血糖及餐后2 h 血糖均明显降低,三组治疗后餐前胰岛素,餐后胰岛素有下降,而胰岛素敏感指数升高。在全面控制糖代谢紊乱方面,本文表明小剂量混合胰岛素与二甲双胍合用效果最佳,对合并有肝肾功能有损害的SFS者,则以小剂量混合胰岛素与拜糖平合用较为安全。

关 键 词:2型糖尿病  继发性磺脲类药物失效  对比研究

An Observation of Three Therapeutic Methods in the Treatment of Type 2 Diabetes Mellitus with Secondary Failure of Sulfonylurea
Lai Xiaoyang Zou Wenhua Wang Zongshun Zhang Meiying,Yu Rong Liu Zelin.An Observation of Three Therapeutic Methods in the Treatment of Type 2 Diabetes Mellitus with Secondary Failure of Sulfonylurea[J].Acta Academiae Medicinae Jiangxi,1999,39(3):75-78.
Authors:Lai Xiaoyang Zou Wenhua Wang Zongshun Zhang Meiying  Yu Rong Liu Zelin
Abstract:Sixty patients suffering from type 2 diabetes mellitus with secondary failure of sulfonylurea (SFS) and under conditions of controlled diet and physical activities were divided into three groups and treated with:combination of metformine and acarbose (group A),combination of a small dose Noveline 30R and acarbose (group B) and combination of a small dose Noveline 30R and metformine (group C).After 3 months of treatment,the levels of fasting and 2-hour postprandial blood glucose decreased significantly.The levels of fasting and 2-hour postprandial insuline decreased,while index of insuline sensitivity increased.It is shown that the combination of small dose Noveline 30R and metformine is of the best efficacy.For the patients of type 2 diabetes mellitus SFS with damage of liver and kidney,the combination of Noveline 30R and acarbose is safer.
Keywords:diabetes mellitus  type2Complement words  secondary failure of sulfonylurea  *  comparative study
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号